Trials / Completed
CompletedNCT00676897
Statin Therapy in the Treatment of Sepsis
Study of Statin Therapy in the Treatment of Sepsis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Simvastatin will attenutat IL-6 levels and lead to a more rapid shock reversal than placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simvastatin | Simvastatin 40mg PO or NGT |
| DRUG | Placebo | Corn Starch |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2008-05-13
- Last updated
- 2017-06-14
- Results posted
- 2017-06-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00676897. Inclusion in this directory is not an endorsement.